Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  This interim guidance is effective as of February 3, 2020, and does not apply retrospectively to people who have been in China during the previous 14 days and are already in the United States, or those being managed as part of a contact investigation.
  
  CDC will provide separate guidance for healthcare settings.
  
  Background -- Purpose -- Definitions Used in this Guidance -- Exposure Risk Categories -- Recommendations for Exposure Risk Management -- Travelers from China -- Airline Crew -- People with confirmed 2019-nCoV infection and symptomatic Patients Under Investigation for 2019-nCoV infection -- Table: Summary of CDC Recommendations for Management of Persons with Potential 2019-nCoV Exposure by Risk Level and Symptoms
  
  
• Subjects:
  Coronavirus Infections COVID-19 Managment Risk Assessment Travel
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Genre:
  Guideline
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:29b19dd9caf222ef45b326ce3faae7ca61156ee42dc7423251b811bfe11882cf7526cefb81de446ddaf10d58aa35a89645d701b9156f8d5f2057579ec015c60b
• Download URL:
  https://stacks.cdc.gov/view/cdc/84776/cdc_84776_DS1.pdf
• File Type:
  [PDF - 691.22 KB ]